Ausper Biopharma Co., Ltd.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS8
PHASE 3 / 2-31
RECRUITING4
READOUTS ≤12 MONTHS5
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| AHB-137 NCT06829329 |
P2 | Active, not recruiting | Chronic Hepatitis B | 105 | 2026-08-02 (+9 mo) |
| AHB-137 NCT07137910 |
P2 | Recruiting | Chronic Hepatitis B | 200 | 2026-12-12 (+11 mo) |
| AHB-137 NCT07246889 |
P3 | Active, not recruiting | Chronic Hepatitis B | 577 | 2026-12-18 |
| AHB-137 NCT07635186 |
P2 | Recruiting | Chronic Hepatitis B | 320 | 2027-06-20 |
| AHB-137 NCT07069569 |
P2 | Recruiting | Chronic Hepatitis B | 200 | 2027-07-15 (+6 mo) |
| AHB-137 NCT06993480 |
P2 | Active, not recruiting | Chronic Hepatitis B | 20 | 2027-07-27 (+13 mo) |
| AHB-137 NCT07876856 |
P1/2 | Not yet recruiting | Chronic Hepatitis B | 105 | 2028-09-22 |
| AHB-171 Injection NCT07630727 |
P2 | Recruiting | Hepatitis B, Chronic (CHB) | 138 | 2029-03-31 |